Optimum Ethics Review Board (ERB) is an independent ethics review
board (also called an IRB
or REB) that is constituted and operates
according to Division 5 of the Food and Drug Regulations,
ICH/GCP
Guidelines, FDA 21 CFR Parts 50 & 56, DHHS Section 45 CFR 46, the
Declaration of Helsinki, FDA Information Sheets: Guidance for IRBs
and Clinical Investigators and the Tri-Council Policy Statement for
Ethical Conduct of Research Involving Humans.
It was formed in September 1995, to respond to the needs of
investigators and the pharmaceutical industry. It is comprised of
members with diverse and varying backgrounds in the medical,
physical and social sciences. |